Cargando…
(+)-Dehydroabietic Acid, an Abietane-Type Diterpene, Inhibits Staphylococcus aureus Biofilms in Vitro
Potent drugs are desperately needed to counteract bacterial biofilm infections, especially those caused by gram-positive organisms, such as Staphylococcus aureus. Moreover, anti-biofilm compounds/agents that can be used as chemical tools are also needed for basic in vitro or in vivo studies aimed at...
Autores principales: | Fallarero, Adyary, Skogman, Malena, Kujala, Janni, Rajaratnam, Mohanathas, Moreira, Vânia M., Yli-Kauhaluoma, Jari, Vuorela, Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709773/ https://www.ncbi.nlm.nih.gov/pubmed/23739682 http://dx.doi.org/10.3390/ijms140612054 |
Ejemplares similares
-
Systematic Exploration of Natural and Synthetic Flavonoids for the Inhibition of Staphylococcus aureus Biofilms
por: Manner, Suvi, et al.
Publicado: (2013) -
Prevention of Staphylococcus aureus biofilm formation by antibiotics in 96-Microtiter Well Plates and Drip Flow Reactors: critical factors influencing outcomes
por: Manner, Suvi, et al.
Publicado: (2017) -
Printed paper-based arrays as substrates for biofilm formation
por: Määttänen, Anni, et al.
Publicado: (2014) -
Optimization of a High-Throughput 384-Well Plate-Based Screening Platform with Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 15442 Biofilms
por: Gilbert-Girard, Shella, et al.
Publicado: (2020) -
Screening of FDA-Approved Drugs Using a 384-Well Plate-Based Biofilm Platform: The Case of Fingolimod
por: Gilbert-Girard, Shella, et al.
Publicado: (2020)